According to BeiGene 's latest financial reports the company's total assets are $5.80 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $5.80 B | -9% |
2022-12-31 | $6.37 B | -25.26% |
2021-12-31 | $8.53 B | 52.4% |
2020-12-31 | $5.60 B | 247.38% |
2019-12-31 | $1.61 B | -28.33% |
2018-12-31 | $2.24 B | 114.98% |
2017-12-31 | $1.04 B | 157.87% |
2016-12-31 | $0.40 B | 247.55% |
2015-12-31 | $0.11 B | 117.76% |
2014-12-31 | $53.62 M | 354.49% |
2013-12-31 | $11.79 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $2.01 B | -65.35% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $27.03 M | -99.53% | ๐บ๐ธ USA |